Eli Lilly & Co. is buying three clinical-stage vaccine developers for as much as $3.8 billion, leveraging its obesity-fueled ...

Eli Lilly agreed to buy three vaccine developers targeting shingles, bacterial infections and Epstein-Barr Virus.

Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein Barr virus (EBV), a pathogen estimated to infect 95% of the global population that is linked to multiple types of ...

Scientists at the National Institutes of Health have identified structural weak points on the Epstein-Barr virus that allowed them to develop a monoclonal antibody capable of blocking infection in ...

The Epstein-Barr virus (EBV) can cause certain types of cancer or autoimmune diseases, but how the body controls this common viral infection is largely unknown. Researchers at the University Hospital ...

Eli Lilly & Co agreed to buy three vaccine developers for a total of up to about US$3.8 billion, marking the drugmaker’s ...